Understand why stem cell treatments for MS are causing much excitement
Widely considered one of the most highly effective treatment methods for multiple sclerosis (MS), stem cell treatments for MS provide many sufferers of this debilitating illness with great hope. The empirical evidence continues to gain traction in combination with the many positive patient testimonials from the stem cell clinics located throughout many regions of the world.
MS is a debilitating illness that has a significantly negative effect on your brain, vision and spinal cord. In addition to vision problems, it can also create problems with muscle control, balance and other bodily functions.
The effects felt by individuals tend to differ drastically from person to person. While some sufferers will experience slight symptoms that require little in the way of treatment, others will be significantly affected and struggle to perform even the simplest of daily tasks.
MS occurs when a person's immune system attacks myelin. Myelin is a combination of proteins and phospholipids that forms a sheath which wraps around many nerve fibers as a form of protection.
When Myelin is attacked and the nerves are damaged, the result is that signals sent from the brain aren't sent correctly throughout the body.
Symptoms that will most commonly be experienced by MS sufferers include:
The onset of MS most commonly occurs between the ages of 22 and 40. However, people can contract the disease at any stage of life, from a very young age right through to the later years. While for some, the symptoms are felt infrequently, for others the illness gets worse as time goes by.
While the research is not conclusive, there are a number of factors that seem to increase the risk of contracting MS. These factors include:
Traditionally, most mainstream treatment methods for MS involve the prescription of drugs to help assist the damage to nerves. Steroids are also commonly prescribed to minimize the intensity of MS attacks. Muscle relaxants and tranquilizers have also been provided to sufferers to treat some of the symptoms.
In addition, many GP's will also encourage sufferers to visit a physical therapist. The therapist can educate the sufferer about certain exercises that can assist in boosting strength and helping with reducing pain and fatigue.
However, the effectiveness of traditional treatment has been shown to be rather limited in many cases, especially for those with severe symptoms.
Encouragingly, Stem Cell Treatments for MS are continuing to produce exciting results. This is great news for those who are finding more traditional methods to be largely ineffective.
Treatment for MS using stem cell therapy differs greatly to non-stem cell treatment methods. Rather than standard treatment which aims to suppress the immune system, stem cell therapy aims to reset the immune system in an effort to overcome the debilitating symptoms.
There are currently several different ways that stem cells are being used in the treatment of MS. One such area of current interest is the exploitation of neuroprotective properties via mobilization of administered stem cells.
There have been a number of clinical human trials conducted worldwide that lend tremendous support to the effectiveness that stem cell treatments for MS can provide for chronic sufferers.
A 2012 Chinese study investigated the effect of stem cell therapy on 25 patients. The patients participating in the study all had experienced varying degrees of severity in relation to MS. Following the clinical trial, several patients experienced cognitive improvement, progression and stabilization. The researchers were able to conclude that the specific Stem Cell treatment for chronic MS sufferers was favorable.
Another study into the effectiveness of stem cells as a treatment method for MS sufferers was performed in 2011 reported very encouraging results. Long-term findings were submitted in late 2016 to the American Academy of Neurology and suggested that long-term results were far more effective than the most readily available medications for people with particular kinds of MS. Those treated with stem cells showed no disease progression with some participants showing significant improvements including improved mobility.
Another recent study tested the effectiveness of hematopoietic stem cell transplantation (HSCT) against more traditional forms of treatment. Researchers reported that those patients given stem cells instead of disease-modifying treatment were far less likely to experience disease progression. Researchers were able to conclude that the administering of stem cells will be far more likely to slow the progression of MS when compared to the more common forms of treatment.
At Stemaid Institute Europe, the treatment process for MS involves three steps.
The first step is the eradication of parasites and toxins that are a direct cause of the inflammation experienced by patients. This is followed by the subsequent regulation of the immune system. Finally, following the regulation of the immune system, repair of the damage that has been caused by MS is performed thanks to a complete neuron rebuild.
Treatment length will vary depending on the severity of the damage that has been experienced as a result of MS.
As is clear from the clinical trials that have been performed in recent years, the effectiveness of stem cells as a treatment method provides plenty of optimism for those suffering severe symptoms as a result of MS. We can only expect more and more support for this form of treatment as clinical studies are undertaken in conjunction with the many patient testimonials that continue to flood in.
Bing Chen, Min Zhou, Jian Ouyang, Rongfu Zhou, Jingyan Xu, Qiguo Zhang, Yonggong Yang, Yong Xu, Xiaoyan Shao, Li Meng, Jing Wang, Yun Xu, Xiushi Ni, & Xueguang Zhang. (2012). Long-term efficacy of autologous haematopoietic stem cell transplantation in multiple sclerosis at a single institution in China
Burt, Richard., Balabanov, R., & Burman, J. (2019). Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis.